Iodine & Tyrosine オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

iodine & tyrosine

rn labs pty ltd - potassium iodide, quantity: 300 microgram (equivalent: iodine, qty 225 microgram); tyrosine, quantity: 500 mg - capsule, hard - excipient ingredients: hypromellose; colloidal anhydrous silica - helps improve/promote body metabolism/metabolic rate ; helps enhance/promote general health and wellbeing ; maintain/support healthy thyroid gland function ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency

Ketuzz オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

ketuzz

ttb international pty ltd - tyrosine, quantity: 30 mg; phenylalanine, quantity: 68 mg; lysine hydrochloride, quantity: 131.25 mg (equivalent: lysine, qty 105 mg); isoleucine, quantity: 67 mg; valine, quantity: 86 mg; leucine, quantity: 101 mg; dl-methionine, quantity: 59 mg; histidine, quantity: 38 mg; tryptophan, quantity: 23 mg; threonine, quantity: 53 mg; calcium carbonate, quantity: 125 mg (equivalent: calcium, qty 50 mg); carnauba wax - tablet, film coated - excipient ingredients: maize starch; calcium hydrogen phosphate dihydrate; povidone; hydrogenated vegetable oil; crospovidone; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; hypromellose; macrogol 400; titanium dioxide; brilliant blue fcf; sunset yellow fcf; tartrazine - 1, contains 10 amino acids. 2, support protein synthesis in the body. 3, help maintain healthy kidney function. 4, support general wellbeing.

Ketosile オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

ketosile

ttb international pty ltd - tyrosine, quantity: 30 mg; phenylalanine, quantity: 68 mg; lysine hydrochloride, quantity: 131.25 mg (equivalent: lysine, qty 105 mg); isoleucine, quantity: 67 mg; valine, quantity: 86 mg; leucine, quantity: 101 mg; dl-methionine, quantity: 59 mg; histidine, quantity: 38 mg; tryptophan, quantity: 23 mg; threonine, quantity: 53 mg; calcium carbonate, quantity: 125 mg (equivalent: calcium, qty 50 mg); carnauba wax - tablet, film coated - excipient ingredients: maize starch; calcium hydrogen phosphate dihydrate; povidone; hydrogenated vegetable oil; crospovidone; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; hypromellose; macrogol 400; titanium dioxide; brilliant blue fcf; sunset yellow fcf; tartrazine - 1, contains 10 amino acids. 2, support protein synthesis in the body. 3, help maintain healthy kidney function. 4, support general wellbeing.

MICRO-TYROSINE オーストラリア - 英語 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

micro-tyrosine

sharen k madin - tyrosine-dl - no types entered yet - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - electrolytes

Heat オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

heat

catalo naturals (australia) pty ltd - tyrosine, quantity: 250 mg; plectranthus barbatus, quantity: 130.7692 mg (equivalent: plectranthus barbatus, qty 8.5 g); piper nigrum, quantity: 2.5 mg (equivalent: piper nigrum, qty 125 mg); commiphora myrrha, quantity: 150 mg (equivalent: commiphora myrrha, qty 1.5 g); camellia sinensis, quantity: 150 mg (equivalent: camellia sinensis, qty 3.75 g; equivalent: catechins (of camellia sinensis), qty 90 mg; equivalent: epigallocatechin-3-0-gallate, qty 45 mg; equivalent: caffeine, qty 12.75 mg); fucus vesiculosus, quantity: 18 mg (equivalent: fucus vesiculosus, qty 72 mg) - capsule, hard - excipient ingredients: crospovidone; magnesium stearate; sodium hydroxide; povidone; propylene glycol; colloidal anhydrous silica; brilliant blue fcf; titanium dioxide; maltodextrin; shellac; magnesium carbonate hydrate; quinoline yellow; calcium hydrogen phosphate dihydrate; carmoisine; microcrystalline cellulose; silicon dioxide; purified water; gelatin; sodium lauryl sulfate - helps reduce/decrease free radical damage to body cells ; helps decrease/reduce body weight ; helps in the maintenance of a healthy body weight ; helps maintain/support healthy body mass index (bmi) ; helps enhance/promote/increase body fat loss ; helps enhance/promote/increase weight loss ; helps in the maintenance of healthy blood lipids/blood fats ; helps maintain/support healthy cholesterol ; maintain/support thyroid gland health ; aid/assist thyroid hormone production

ORFADIN nitisinone 10 mg capsule bottle オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

orfadin nitisinone 10 mg capsule bottle

a menarini australia pty ltd - nitisinone, quantity: 10 mg - capsule, hard - excipient ingredients: pregelatinised maize starch; titanium dioxide; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; ethanol absolute; iron oxide black; potassium hydroxide - orfadin (nitisinone) is indicated for the treatment of patients with hereditary tyrosinaemia type 1 in combination with dietary restriction of tyrosine and phenylalanine.

ORFADIN nitisinone 5 mg capsule bottle オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

orfadin nitisinone 5 mg capsule bottle

a menarini australia pty ltd - nitisinone, quantity: 5 mg - capsule, hard - excipient ingredients: gelatin; titanium dioxide; pregelatinised maize starch; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; ethanol absolute; iron oxide black; potassium hydroxide - orfadin (nitisinone) is indicated for the treatment of patients with hereditary tyrosinaemia type 1 in combination with dietary restriction of tyrosine and phenylalanine.

ORFADIN nitisinone 2 mg capsule bottle オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

orfadin nitisinone 2 mg capsule bottle

a menarini australia pty ltd - nitisinone, quantity: 2 mg - capsule, hard - excipient ingredients: titanium dioxide; gelatin; pregelatinised maize starch; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; ethanol absolute; iron oxide black; potassium hydroxide - orfadin (nitisinone) is indicated for the treatment of patients with hereditary tyrosinaemia type 1 in combination with dietary restriction of tyrosine and phenylalanine.